SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 192.83 |
| Enterprise Value ($M) | 92.53 |
| Book Value ($M) | 530.70 |
| Book Value / Share | 1.82 |
| Price / Book | 0.36 |
| NCAV ($M) | 361.53 |
| NCAV / Share | 1.24 |
| Price / NCAV | 0.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.43 |
| Current Ratio | 13.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 450.05 |
| Assets | 619.22 |
| Liabilities | 88.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ARCH Venture Fund IX, L.P. | |||
| 13G/A | Foresite Capital Fund IV, L.P. | |||
| 13G/A | BlackRock, Inc. | |||
| 13G/A | Vanguard Group Inc | 3.93 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 190,029 | 1,008,856 | 18.84 | |
| 190,052 | 1,322,648 | 14.37 | |
| 201,859 | 564,628 | 35.75 | |
| 159,133 | 752,020 | 21.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KYTX – Kyverna Therapeutics, Inc. | LVTX – LAVA Therapeutics N.V. |
| LXRX – Lexicon Pharmaceuticals, Inc. | MCRB – Seres Therapeutics, Inc. |
| MDGL – Madrigal Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io